Insulet
PODD
#1279
Rank
NZ$29.30 B
Marketcap
NZ$416.37
Share price
-2.08%
Change (1 day)
-16.00%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2025 (TTM): NZ$6.10

According to Insulet's latest financial reports the company's current EPS (TTM) is NZ$5.80. In 2024 the company made an earnings per share (EPS) of NZ$9.91 an increase over its 2023 EPS that were of NZ$4.89.

EPS history for Insulet from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.10-38.46%
2024NZ$9.91102.71%
2023NZ$4.894114.29%
2022NZ$0.12-69.57%
2021NZ$0.38109.09%
2020NZ$0.18-38.89%
2019NZ$0.30200%
2018NZ$0.09944-113.04%
2017NZ-$0.76-9.8%
2016NZ-$0.85-60.47%
2015NZ-$2.1438.71%
2014NZ-$1.5412.05%
2013NZ-$1.38-23.15%
2012NZ-$1.79-12.2%
2011NZ-$2.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.30 198.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.35 130.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.15 6.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$34.01 486.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$5.06-187.14%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ-$0.51-108.86%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$3.07-47.14%๐Ÿ‡บ๐Ÿ‡ธ USA